FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/08/2022
Voltar para busca
Dado oficial do USPTO
INSTITUT CURIE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
29/08/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
36, 42, 44
Data de depósito
27/08/2020
Data de registro
15/03/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/03/2022
Última transação
15/03/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
MORRIS, KRISTINA
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a gray and an orange overlapping circle, each containing a triangle, above the stylized gray wording "INSTITUT" above the stylized orange wording "CURIE". The color white represents background, and transparent areas and is not part of the mark.
Titulares e representantes
Titulares
INSTITUT CURIE
Representantes
Maurice B. Pilosof MAURICE B. PILOSOF, ESQ.
Classificação técnica
Classes Nice
Classe 36Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 36
Fundraising services, namely, charitable fundraising; financial sponsoring of cancer research
Classe 42
Scientific and medical research services, product development in the industrial, scientific, medical, pharmaceutical and biological field; conducting clinical trials for others; scientific laboratory services; medical and scientific analyses, namely, DNA analysis for scientific research purposes; research in biology, biotechnology, chemistry, bacteriology and chemotherapy; quality control; conversion of data or documents from physical to electronic media; reconstruction of database systems for others; research and development of new products for third parties; technical project study, namely, conducting scientific feasibility studies; evaluations in the scientific, medical and technological fields, namely, conducting early evaluations in the field of new cancer treatment, new molecules in immuno-oncology, materials testing and evaluations; estimations in the scientific, medical and technological fields, namely, pharmaceutical products evaluation; research in the scientific and medical fields; technological research in the fields of medical apparatus and instruments; clinical studies, namely, conducting clinical trials for others; development of diagnostic methods for cancer treatment; development of new products for others, namely, products or materials intended for use in patient care paths, diagnoses, prognostics or therapy
Classe 44
Medical services; health services, namely, health care; therapeutic services, namely, therapeutic cancer services; medical services relating to diagnosis and care and management; medical consultations; medical assistance; medical and pharmaceutical consultation relating to pharmacy, relating to public health, relating to pharmaceutical products; veterinary services; advisory services relating to health; convalescent and rest home services; hospital services; medical equipment rental; medical analysis services relating to the treatment of persons; services of a psychologist; genetic consultation for medical purposes; medical screening; dispensing of pharmaceuticals; medical information; conducting of medical examinations; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; medical analysis services for cancer diagnosis and prognosis; medical clinic and hospital services; nursing care; medical care; DNA screening for medical purposes; beauty care services
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/08/2022
FIMP
FINAL DISPOSITION PROCESSED
10/08/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
15/03/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/12/2021
PUBO
PUBLISHED FOR OPPOSITION
28/12/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/12/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
22/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
22/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/10/2021
ALIE
ASSIGNED TO LIE
24/10/2021
NREV
NOTICE OF REVIVAL - E-MAILED
18/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/10/2021
PETG
PETITION TO REVIVE-GRANTED
18/10/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
18/10/2021
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
19/08/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
19/08/2021
RFNT
REFUSAL PROCESSED BY IB
01/03/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/02/2021
RFRR
REFUSAL PROCESSED BY MPU
05/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/01/2021
CNRT
NON-FINAL ACTION WRITTEN
14/01/2021
DOCK
ASSIGNED TO EXAMINER
29/12/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INSTITUT CURIE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.